Nouvelles drogues de synthèse en addictovigilance
Therapie, 70 2 (2015) 167-178
Published online: 2015-04-09
Articles citing this article
The Citing articles tool gives a list of articles citing the current article.
The citing articles come from EDP Sciences database, as well as other publishers participating in CrossRef Cited-by Linking Program. You can set up your personal account to receive an email alert each time this article is cited by a new article (see the menu on the right-hand side of the abstract page).
Cited article:
This article has been cited by the following article(s):
Addictovigilance: The Edge of reason?
Maryse Lapeyre-Mestre, Joelle Micallef, Amélie Daveluy, Reynald Le Boisselier, Célian Bertin, Nathalie Fouilhe Sam-Lai, Régis Bordet, Alexandra Boucher, Joëlle Micallef, Hélène Peyrière, Pierre Gillet, Caroline Victorri-Vigneau, Anne Batisse, Marie-Christine Perault-Pochat and Maryse Lapeyre-MestreTherapies 80 (2) 155 (2025)
https://doi.org/10.1016/j.therap.2025.01.001
Simultaneous Determination of 16 Kinds of Synthetic Cathinones in Human Urine Using a Magnetic Nanoparticle Solid-Phase Extraction Combined with Gas Chromatography-Mass Spectrometry
Dan Wang, Xueguo Chen, Zhu Ming, Limin Jiang and Yan ZhouSeparations 9 (1) 3 (2021)
https://doi.org/10.3390/separations9010003
Enantioseparation and Determination of Mephedrone and Its Metabolites by Capillary Electrophoresis Using Cyclodextrins as Chiral Selectors
Pavel Řezanka, Denisa Macková, Radek Jurok, Michal Himl and Martin KuchařMolecules 25 (12) 2879 (2020)
https://doi.org/10.3390/molecules25122879
Cannabis Use Disorders
Laurent Karila and Amine BenyaminaCannabis Use Disorders 169 (2019)
https://doi.org/10.1007/978-3-319-90365-1_16
Ephenidine, diphenidine, and methoxphenidine complications reported to the French Addictovigilance Network
Céline Eiden, Sarah Leone‐Burgos, Anaïs Serre, Louise Carton, Marie Gerardin, Reynald Le Boisselier, Valérie Gibaja, Emilie Monzon, Nathalie Fouilhe, Alexandra Boucher and Hélène PeyriereFundamental & Clinical Pharmacology 32 (6) 654 (2018)
https://doi.org/10.1111/fcp.12395
Intérêt de la mise à disposition de la naloxone auprès des usagers de drogues pour le traitement d’urgence de surdosage d’opioïdes
Elisabeth Frauger, Farid Kheloufi, Quentin Boucherie, et al.Therapies 73 (6) 511 (2018)
https://doi.org/10.1016/j.therap.2018.07.001
Nouveaux produits de synthèse (NPS) et addictovigilance : de la pharmacodynamie théorique aux complications somatiques réelles
J. MicallefToxicologie Analytique et Clinique 30 (2) S44 (2018)
https://doi.org/10.1016/j.toxac.2018.04.053
Implication de l’addictovigilance dans un service d’urgence pour la détection et le recueil des cas d’abus et de dépendance : bilan de 3 ans d’expérience
Anaïs Serre, Céline Eiden, Vincent Gourhant, et al.Therapies 73 (6) 501 (2018)
https://doi.org/10.1016/j.therap.2018.06.002
Cannabis, cannabinoids, and health
Genevieve Lafaye, Laurent Karila, Lisa Blecha and Amine BenyaminaDialogues in Clinical Neuroscience 19 (3) 309 (2017)
https://doi.org/10.31887/DCNS.2017.19.3/glafaye
The Novel Psychoactive Substances in the UK Project: empirical and conceptual review work to produce research recommendations
Noreen D Mdege, Nick Meader, Charlie Lloyd, Steve Parrott and Jim McCambridgePublic Health Research 5 (4) 1 (2017)
https://doi.org/10.3310/phr05040
Cannabinoïdes de synthèse : une nouvelle matrice des addictions
Amandine Scocard, Amine Benyamina, Sarah Coscas and Laurent KarilaLa Presse Médicale 46 (1) 11 (2017)
https://doi.org/10.1016/j.lpm.2016.11.014
Effets uro-néphrologiques des produits utilisés par les usagers de drogues : revue de la littérature et enquête pharmaco-épidémiologique en France et dans la région de Marseille
Marion Gully, Élisabeth Frauger, Michel Spadari, et al.Néphrologie & Thérapeutique 13 (6) 429 (2017)
https://doi.org/10.1016/j.nephro.2017.01.024
Methoxphenidine Use Disorder
William Champeau, Céline Eiden, Julien Gambier and Hélène PeyriereJournal of Clinical Psychopharmacology 37 (3) 376 (2017)
https://doi.org/10.1097/JCP.0000000000000684
Les aspects actuels de l’usage de l’ecstasy/MDMA en France
Michel Spadari, Anne Batisse, Marylène Guerlais, et al.Therapies 71 (6) 553 (2016)
https://doi.org/10.1016/j.therap.2016.05.005
Synthetic cannabinoid (K2) use in pediatric patients and cardiovascular events: A place for pericarditis and myopericarditis?
Joachim Alexandre, Sophie Fedrizzi, Danièle Debruyne, Antoine Coquerel and Reynald Le BoisselierThe Journal of Pediatrics 167 (6) 1454 (2015)
https://doi.org/10.1016/j.jpeds.2015.08.063